The tumor suppressor PTEN controls cell proliferation by regulating phosphatidylinositol-3-kinase (PI3K) activity, but the participation of PTEN in host defense against bacterial infection is less well understood. Anti-inflammatory PI3K-Akt signaling is suppressed in patients with cystic fibrosis (CF), a disease characterized by hyper-inflammatory responses to airway infection. We found that Ptenl À/À mice, which lack the NH 2 -amino terminal splice variant of PTEN, were unable to eradicate Pseudomonas aeruginosa from the airways and could not generate sufficient anti-inflammatory PI3K activity, similar to what is observed in CF. PTEN and the CF transmembrane conductance regulator (CFTR) interacted directly and this interaction was necessary to position PTEN at the membrane. CF patients under correctorpotentiator therapy, which enhances CFTR transport to the membrane, have increased PTEN amounts. These findings suggest that improved CFTR trafficking could enhance P. aeruginosa clearance from the CF airway by activating PTEN-mediated anti-bacterial responses and might represent a therapeutic strategy.
In Brief
Anti-inflammatory PI3K-Akt signaling is suppressed in patients with cystic fibrosis (CF), a disease characterized by hyper-inflammatory responses to airway infection. Riquelme et al. find that CFTR channel directly interacts with tumor suppressor PTEN, which regulates PI3K activity. CFTR helps position PTEN at the membrane to promote PTEN function and host immunity against Pseudomonas aeruginosa infection.
INTRODUCTION
The recognition of pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharides (LPS), by Toll-like receptor (TLRs) and the activation of pro-inflammatory signaling are essential components of the innate immune defense in airways (Akira and Takeda, 2004) . The regulation of this response is equally important, mediated to a substantial degree by the phosphatidylinositol components of the plasma membrane (Bae et al., 2017; Hawkins and Stephens, 2015) . Phosphatidylinositol-(4,5)-biphosphate (PIP 2 ) production is fundamental for the proper assembly of the complex that regulates LPS-TLR4
signaling. This consists of the TIR domain containing adaptor protein (TIRAP)-class I PI3K-Akt core, a multi-protein structure docked to PIP 2 at the inner leaflet of the cell membrane that signals downstream through Akt to switch off inflammatory nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) activity (Aksoy et al., 2012; Kaneda et al., 2016; Laird et al., 2009 ). The generation of PIP 2 is a dynamic process mediated by different membrane-attached kinases as well as by phosphatase and tensin homolog PTEN, a wellknown tumor suppressor that restricts cell proliferation by converting PIP 3 into PIP 2 (Bunney and Katan, 2010) . Because PTEN is critical in generating PIP 2 , PTEN is likely to participate in the assembly of the anti-inflammatory TIRAP-PI3K-Akt complex that controls TLR4 signaling. However, this hypothesis remains to be tested.
Anti-inflammatory PI3K-Akt signaling is suppressed in cystic fibrosis (CF) (Zhang et al., 2015; Zhang et al., 2013) , a disease resulting from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) and characterized by hyper-inflammatory responses to airway infection (Bonfield et al., 2012; Elborn, 2016; Gosselin et al., 1998) . Lack of CFTR at the cell surface interferes with the clearance of Pseudomonas aeruginosa, the major pathogen in CF, suggesting an as yet undefined association between mutations in CFTR (Elborn, 2016) and the regulation of the anti-P. aeruginosa host immunity (Cohen and Prince, 2012) .
Both the catalytic p110 (d and g) and regulatory p85a subunits of class I PI3K interact with PTEN and facilitate its activation (Chagpar et al., 2010; Pé rez-García et al., 2014; Rabinovsky et al., 2009) , which includes dephosphorylation of its C terminus, dimerization at the plasma membrane and PIP 2 production (Papa et al., 2014; Rahdar et al., 2009; Vazquez et al., 2000) . Given this cooperative and likely immune regulatory PI3K-PTEN interaction, and because PTEN null mutations are embryonic lethal (Di Cristofano et al., 1998) , PTEN has been studied mainly in myeloid (Huang et al., 2012; Kral et al., 2016; Schabbauer et al., 2010; Zaidi and Manna, 2016) and airway cells (Kwak et al., 2003) . A splice variant of PTEN, PTEN-Long (PTEN-L) has a polycation NH 2 terminus facilitating its secretion and possible interaction with the negatively charged inner leaflet of the plasma membrane (Hopkins et al., 2013 functions fully mimic those of the parent protein making it suitable for testing PTEN-PI3K immune regulatory function in vivo.
CFTR is trafficked to the cell surface with variable efficiency in CF patients depending upon the nature of the CFTR mutation (Elborn, 2016) . CFTR correctors, such as lumacaftor, help chaperone mutant CFTR to the plasma membrane, substantially improving CF-associated symptoms in patients with mutations amenable to this therapy (Boyle et al., 2014) . CFTR potentiators, such as ivacaftor, are also available, functioning to improve CFTR channel activity, once the mutant CFTR is mobilized to the plasma membrane. Although widely used clinically, whether these drugs regulate other proteins that control host immunity remains unknown.
In the experiments detailed in this report, we demonstrated that the immune PTEN-PI3K regulation depended on both the presence of CFTR at the cell surface and its interaction with PTEN. This interaction did not require CFTR channel function and resulted in reduced P. aeruginosa-mediated inflammation and diminished intracellular bacterial survival in mice. We showed that CF patients with CFTR mutations amenable to corrector-potentiator therapy have increased co-localization of PTEN and CFTR, suggesting that improved CFTR trafficking could enhance P. aeruginosa clearance from the CF airway.
RESULTS

PTEN Prevents TIRAP-p110d Depletion during P. aeruginosa Lung Infection
The host response to airway pathogens such as P. aeruginosa is initiated by TLR4-activated inflammatory signaling. In parallel, a regulatory complex is assembled that includes the PIP 2 -dependent membrane adaptor TIRAP and the anti-inflammatory subunit of PI3K p110 (d and g) (Aksoy et al., 2012; Kaneda et al., 2016) . PIP 2 protects TIRAP-p110dÀg from degradation and together shuts down NF-kB inflammatory activity. The dynamics of these interactions were observed in murine bone-marrowderived macrophages (BMDMs) and in human monocytic cells. The mean fluorescence intensities (MFI) corresponding to TIRAP and the two catalytic isoforms of PI3K p110d and p110g were substantially reduced in response to P. aeruginosa infection and with a reduction of the PIP 2 producer PTEN ( Figures  1A-1D and Figure S1 ). While PIP 2 anchors TIRAP to the cell membrane (Kagan and Medzhitov, 2006) , the p85 subunit of PI3K links the kinase to TIRAP and Myeloid differentiation primary response 88 (MyD88) (Laird et al., 2009 ) and p110 interacts with PTEN (Chagpar et al., 2010; Pé rez-García et al., 2014; Rabinovsky et al., 2009 ). Due to their physical proximity, we expected that the amount of available PTEN would be critical in the assembly and stability of the TIRAP-PI3K anti-inflammatory signaling complex. To determine whether the amounts of PTEN available regulated the components of the signaling complex, we studied the response of Ptenl À/À mice to P. aeruginosa infection.
Ptenl
À/À mice lacking the NH 2 -amino terminal splice variant of PTEN (PTEN-Long) that accounts for approximately 20% of the total PTEN phosphatase pool (Hopkins et al., 2013) were generated ( Figures S2A-S2D ) and infected intranasally with P. aeruginosa. In lung lysates of Ptenl À/À mice both TIRAP and p110d proteins were substantially decreased (Figures 1E and 1F) . Elevated concentrations of the NF-kB-dependent cytokines IL-6, IL-1a, IL-1b, and KC were found in bronchoalveolar lavage (BAL) ( Figure 1G ) as well as greater pulmonary damage ( Figure 1H ). These findings were consistent with the proposed loss of PIP 2 and TIRAP-PI3K to switch off NF-kB signaling (Aksoy et al., 2012; Kaneda et al., 2016) . Increased IL-1b and IL-1a in BAL was not due to augmented alveolar macrophage death and cytokine leakage as the integrity of their cell membranes was not compromised ( Figure S2E ). Cytokines dependent upon other signaling pathways were not affected by diminished PTEN (Figures S2F-S2H ). Lack of PTEN-L phosphatase function also decreased the abundance of regulatory T cells (Tregs) (Shrestha et al., 2015) , as previously reported in CF patients (Hector et al., 2015) (Figures S2I and S2J) . These results suggest that PTEN prevented p110d from degradation, possibly through PIP 2 interactions with TIRAP at the cell membrane, as previously described (Aksoy et al., 2012) .
Surface CFTR Regulates PTEN Protein Abundance and Membrane Activity
The hyperinflammatory response of the Ptenl À/À mice to P. aeruginosa pulmonary infection phenocopied the pathology seen in mice and humans with CFTR mutations (Elborn, 2016) . Compared to control cells, both p110d and p110g were rapidly depleted in CF cells after P. aeruginosa infection ( Figure 2A ) as was phospho-Akt ( Figure 2B ), suggesting a link betweeen mutated CFTR and PTEN activity. An association between PTEN and CFTR was also indicated by experiments in which improved trafficking of CFTR to the plasma membrane by incubation at 26 C substantially increased both PTEN and p110d MFI ( Figures S3A-S3F ). The requirement for membrane-anchored CFTR to be present to bind PTEN was further suggested by demonstrating significantly increased intracellular p110d MFI in response to transfection of exogenous PTEN, but only in cells with CFTR at the cell surface ( Figures S3G-S3J ). The CF cells with reduced p110d-phospho-Akt secreted greater amounts of the NF-kB-dependent pro-inflammatory cytokines: IL-6, IL-8, and IL-1b ( Figure 2C ). These observations suggested that CFTR is involved in the regulation of the anti-inflammatory catalytic subunits of PI3K, possibly by regulating PTEN activity.
Most of the mutations that cause clinical diseases result in decreased amounts of CFTR at the cell membrane. We postulated that these mutations would affect amounts of active PTEN and the ability of the cell to regulate inflammation. Intracellular CFTR and PTEN MFI levels in human monocytes from CF patients with either type I or V mutations that decrease CFTR amounts by reduced quality of the CFTR mRNA were quantified by flow cytometry and compared with normal controls. Lack of CFTR protein reduced intracellular PTEN MFI ( Figures 2D-2F ). In addition to insufficient PTEN, lack of CFTR also reduced p110d, phospho-Akt, and TIRAP ( Figure 2G ). Decreased PTEN was also observed in lymphocytes and in neutrophils (Figure S4A ). Using an array of different CFTR mutations, a concave down association was observed between the amounts of CFTR and PTEN present ( Figure S4B ) suggesting that amounts of the
CFTR Cl
À channel directly correlated with amounts of the phosphatase. A more quantitative association was established using human airway epithelial cells homozygous for the most common CFTR type II mutation DF508 transfected with an empty vector (DF508 CFTR) or rescued with a WT CFTR-coding lentivirus (WT CFTR). By increasing CFTR protein MFI and stability by 50%, as quantified by flow cytometry (Figures 2H and 2I) , PTEN MFI were increased by the same proportion (Figures 2J and 2K) . The rescued CF cells also had increased amounts of the phosphorylated p85 component of PI3K that binds PTEN as well as increased phospho-Akt ( Figure 2L ). Substantially more of the stabilized and active dimerized form of PTEN (Papa et al., 2014 ) ( Figure 2M ) and less of the C-terminal phosphorylated PTEN (Rahdar et al., 2009; Vazquez et al., 2000) (Figure 2N) were observed in the rescued CF cells (WT CFTR) than the CF cells (DF508 CFTR). These results were confirmed by flow cytometry demonstrating that in cells with or without P. aeruginosa infection the phospho PTEN-to-total PTEN ratio was decreased in rescued CF cells (Figures 2O and 2P) . CFTR rescue also affected the localization of PTEN, as a greater fraction of PTEN was observed at the plasma membrane (Figure 2Q) . The apparent association between the abundance of CFTR and the recruitment of PTEN dimers to the plasma membrane suggested that the failure of mutant CFTR to reach the cell surface might be responsible for the lack of PTEN membrane localization.
CFTR Corrector-Potentiator Therapy Increases PTEN Protein Amounts in Human Monocytes
The CFTR corrector lumacaftor and potentiator ivacaftor are drugs that correct post-translation-related type II and III CFTR mutations by enhancing mutant CFTR transport to the cell membrane and improving its channel gating activity, respectively Wainwright et al., 2015) . Monocytes that participate in inflammatory processes from CF patients on treatment harboring either type II or III CFTR mutations (e.g., DF508, G85E, and G1244E) had substantially augmented MFI of both CFTR and PTEN, displaying a similar bi-dimensional CFTR-to-PTEN distribution when compared to healthy controls ( Figure 3A , upper-right quadrant, Figure 3B upper panel and Figures 3C and 3D ). However, these drugs rescued neither CFTR nor PTEN MFI in patients with at least one type I or V mutations (e.g., W1282X, Q220X, and G542X), which are not expected to be amenable to modification by these therapeutic agents (Figures 3A and 3B bottom panel and Figures 3C and 3D) . Taken together, these results supported the notion that CFTR regulated PTEN and that transport of mutant CFTR to the cell surface by corrector-potentiator therapy restored PTEN amounts in human cells.
The C-Terminal Domain of CFTR Interacts with PTEN As both CFTR and PTEN function at the cell membrane, a physical interaction between them seemed possible. The cytosolic nucleotide binding domains (NBD) 1 and 2 and the regulatory (R) domain of CFTR can interact with different membrane-attached molecules (Pankow et al., 2015) ( Figure 4A ). CFTR-NBD2 contains the C-terminal tail (CFTR C-term : CFTR 1381-1480 ), which harbors motifs that favor proteinprotein docking such as a PDZ domain (CFTR 1441-1480 ) (Naren et al., 2003) . Using the crystallized CFTR-NBD2 domain (CFTR 1207 (CFTR -1440 ) from the whole non-phosphorylated-closed human CFTR (Liu et al., 2017) (CFTR 1-1440 ) and the human PTEN lacking the C-terminal tail (Lee et al., 1999 ) (PTEN 14-351 ), 70,000 predicted interactions between both were analyzed (ClusPROV2 protein-protein docking modeling, (Kozakov et al., 2017) ). Four main docking candidates where PTEN was facing NBD2 from the cytoplasm were obtained ( Figure 4B for model 1 and Figure S5A for other three models). These models considering the lowest free energy for balanced electrostatic-electrophobic-Van der Waals interactions predicted that the NH 2 terminus and the central core of PTEN (loop and C2 domains) mainly docked with the same CFTR C-term domain (CFTR 1381-1440 ) (red in Figures 4B and 4C and Figure S5A ). Model 1 showed that 20 amino acids housed in the CFTR-NBD2 domain contacted PTEN and these were placed inside the CFTR 1381-1440 region ( Figure S5C ). Similar results were obtained with the other three models using the crystallized human CFTR-NBD2 ( Figure S5A ) and with a previously predicted human CFTR-NBD2 structure (Serohijos et al., 2008) (Figure S5B ), suggesting a dynamic and highly probable interaction. As our bioinformatics models suggested an interaction between the N-terminal and C2 domain of PTEN and the crystallized C terminus of CFTR that lacks the last 40 amino acids (CFTR 1381-1440 of CFTR 1381-1480 ), we performed in silico docking studies between the whole CFTR C-term (CFTR 1381-1480 ) and PTEN. As full CFTR 1381-1480 has not been crystallized yet, we used different bioinformatics algorithms to predict its 3D structure. I-TASSER modeling yielded the most accurate CFTR C-term structure for the first 60 amino acids when compared with the same but already crystallized human CFTR 1381-1440 (Liu et al., 2017) (Figure S5D , CFTR 1381-1440 : red; CFTR 1441-1480 : green). This model placed the last 40 amino acids behind the first 60 residue core, this being the face opened for interactions with cytoplasmic proteins (CFTR 1381 (CFTR -1440 ). Once again, the N terminus of PTEN and the same CFTR 1381-1440 region from I-TASSER modeled CFTR 1381-1480 were predicted to interact in a similar manner when compared to the crystalized CFTR-NBD2 domain (CFTR 1207 (CFTR -1440 ) (Figures 4C and 4D) . Similarities between both models were confirmed after observing that virtually the same amino acids in CFTR and PTEN participated in the interaction ( Figure S5E-S5G) .
The predicted interactions between the C terminus of CFTR and the N-terminal region of PTEN were confirmed by an ELISA capture assay using GST-CFTR C-term (CFTR 1381-1480 ) or GST alone, treated or not with PTEN-containing cell lysates obtained from human bronchial cells (16HBE). A significant PTEN signal above background was detected only in wells coated with GST-CFTR C-term ( Figure 4E ). The association was demonstrated in reverse, coating wells with human recombinant PTEN lacking the C-terminal tail and screening for binding with a CFTR-containing 16HBE lysate, confirming the CFTR and PTEN association ( Figure 4F ). The endogenous proteinprotein interaction in these cells was confirmed by proximity ligation assays (PLA) where CFTR C-term was demonstrated to be responsible for the CFTR-PTEN interaction (Figures 4G and 4H) . CFTR C-term -PTEN docking was also confirmed by immunoprecipitation, documenting that the isolated CFTR 1381-1480 terminus bound the C-terminal deficient form of His-tagged PTEN ( Figure 4I ).
The biological significance of this interaction was established in human monocytes by comparing intracellular MFI of PTEN from controls with full length CFTR (CFTR 1-1480 ) and CF patients with mutations that result in a truncated CFTR lacking the C-terminal portion in the NBD2 domain (CFTR 1-1282 ) ( Figure 4J ). The absence of the CFTR C-term decreased the MFI of PTEN in the cells, indicating that the N terminus PTEN-CFTR 1381-1480 interaction was critical to stabilize the quantity of the phosphatase in human cells. In human monocytes both proteins appeared to colocalize at the cytoplasmic membrane ( Figure 4K ) confirming that the cytoplasmic CFTR C-term tail protruding from the phospholipid bilayer participates as a docking site for PTEN and enhances its stability.
Altogether, these results confirmed that the regulation exerted by CFTR over PTEN was through interactions between their C-and N terminus, respectively. These interactions, appreciated at the cell surface, were key to sustain PTEN quantities in human cells.
CFTR Abundance but not Channel Function Directs PTEN Anti-inflammatory Activity Our findings suggested that the surface localization of CFTR C-term was critical to regulate PTEN, but did not address whether CFTR Cl À channel function was required to maintain adequate PTEN immune function in human monocytes. Our CFTR C-term -PTEN contact models predicted that the phosphatase could bind CFTR independently if the channel is opened or not (e.g., during gating function, Figure 4B ), suggesting that an inactive membrane-bound CFTR could also regulate PTEN function. To address this point, human monocytes were treated for 24 hr with the CFTR activity inhibitor 172 (CFTRinh 172 ) and effects on PTEN were monitored. Substantial CFTR inhibition was confirmed by quantifying a significant increase of total ceramides ( Figure 5A) Figures 5D-5F ). Increased PTEN activity correlated with reduced p110d degradation in P. aeruginosa-infected cells ( Figure 5G ), consistent with the in vivo function of PTEN-L in the setting of acute P. aeruginosa-mediated pneumonia ( Figure 1F ). p110d protein abundance in CFTRinh 172 -treated cells paralleled a marked decrease in NF-kB p65 subunit phosphorylation, despite a substantial increase of this subunit after infection ( Figure 5H ). Reduced p65 phosphorylation was not related to augmented protein amounts of its suppressor IkBa. Despite Cl À channel inhibition, the increased activity of PTEN functioned to reduce NF-kB signaling, as reflected by the reduced amounts of P. aeruginosa-induced IL-8 and IL-1b ( Figure 5I ). This effect of CFTR inhibition, and corresponding increases in CFTR and PTEN did not alter the activation of IL-8, IL-6, or IL-1b as induced by Staphylococcus aureus and Klebsiella pneumoniae, which could be attributed to TLR4 specificity as well as other immunostimulatory properties of these organisms ( Figure 5J (Elborn, 2016; Geborek and Hjelte, 2011; Lording et al., 2006; Sheppard et al., 1993) . We observed that the frequency of P. aeruginosa infection was decreased in patients in whom the amount of non-functional CFTR at the plasma membrane was increased ( Figure 6A , www.cftr2.org). As CFTR regulated PTEN at the surface, we asked whether the phosphatase controlled P. aeruginosa clearance. Total PBMCs from healthy donors were infected or not for 1 hr with P. aeruginosa, washed and incubated with gentamicin for 16 hr ( Figure 6B ). Post-infection inhibition of the phosphatase function with a specific PTEN activity blocker (bpv(HOpic)) reduced the ability of PBMCs to clear intracellular bacteria ( Figure 6B , left panel). However, bacterial survival in CF PBMCs harboring CFTR mutations that reduced PTEN protein abundance did not improve in the presence of the PTEN inhibitor suggesting that these cells had insufficient amounts of the phosphatase to be blocked ( Figure 6B , right panel). Experiments with mice BMDMs supported these conclusions as inhibition of PTEN phosphatase activity in WT/WT Cftr cells mimicked the poor clearance showed by DF508/DF508 Cftr BMDM at initial time-points (PTEN 1-351 ) . PTEN was N terminus tagged with a His-Tag. Anti-GST and anti-His were used to detect both GST-CFTR 1381-1480 , GST and His-rPTEN, respectively. (J) Human PBMCs from both WT (CFTR 1-1480 ) and W1282X mutants CF patients (CFTR 1-1281 ), which lack CFTR C-term were stained for PTEN and analyzed by flow cytometry. (K) Human monocytes were exposed to GFP-expressing P. aeruginosa (PAK, shown as cyan in this picture) (MOI = 10) and stained for CFTR (green), PTEN (red) and nuclei (blue). Where indicated, R1, R2, and R3 are region of interest (ROI) zoomed at the right part of the main figure. Colocalization between CFTR and PTEN can be seen as yellow color in insets. Only one confocal plane is shown. Data was analyzed by using FIJI. White bar represents 3 mmts. (K) represent 4 and (E), (F) and (H) represent 3 independent experiments, respectively. Data is presented as average ± SEM. (E)-(F) were analyzed by two-way ANOVA. (H) was analyzed by one-way ANOVA. For (J), data were analyzed by Student's t-test. *p < 0.05; ***p < 0.001; ****p < 0.0001; ns: non-significant. See also Figure S5 .
( Figure 6C) . A PTEN-specific role in intracellular bacterial killing was confirmed by functional assays in Ptenl À/À BMDMs in which increased P. aeruginosa PAK CFU were recovered from inside the cells as compared to the Ptenl +/+ counterpart ( Figure 6D ), a result confirmed in mouse airways 16 hr after an intranasal P. aeruginosa inoculation ( Figure 6E ).
Because incubation of human monocytes with the CFTRinh 172 reduced CFTR gating function but enhanced PTEN dephosphorylation and phosphatase activity (Figure 5 ), we evaluated whether PTEN-mediated killing was enhanced in these cells. We observed that increased CFTR MFI and PTEN dephosphorylation correlated with increased P. aeruginosa PAK killing ( Figure 6F ). We confirmed that this improved killing was dependent upon PTEN phosphatase function as increasing doses of the bpv(HOpic) blocker abrogated the ability of CFTRinh 172 to enhance P. aeruginosa killing (Figure 6G ), having confirmed that the inhibitor did not have any effects on bacterial growth itself ( Figure 6H ).
Taken together, these results suggested that the capacity of PTEN to promote P. aeruginosa killing depended only on the amount of CFTR but not its Cl À channel function at the cell surface.
DISCUSSION
Our findings suggested that activity of the PIP 2 -dependent TIRAP-PI3K complex that suppresses NF-kB inflammatory signaling depended upon PTEN-CFTR association at the plasma membrane. This adds to the complexity of the established TIRAP-PI3K interaction that controls TLR inflammatory signaling in the plasma membrane (Laird et al., 2009; Santos-Sierra et al., 2009) and suggests an important immunological function for CFTR. In the setting of P. aeruginosa infection p110d and TIRAP protein amounts were actively regulated by PTEN-L in vivo and PTEN in vitro indicating that PIP 2 controlled the assembly and function of this complex. Our data along with several other studies illustrate the anti-inflammatory function of p110d linked to the TLR4-TIRAP signaling (Aksoy et al., 2012; Kaneda et al., 2016; Laird et al., 2009 ). This appears to be distinct from the pro-inflammatory role of p110d in asthma and chronic obstructive pulmonary disease (COPD), where effects on actin-related cell migration and airway obstruction are unrelated to TLR4 (Doukas et al., 2009; Nashed et al., 2007; Sapey et al., 2011) . Most relevant clinically is the observation that intracellular PTEN concentrations are deficient in cells harboring CFTR mutations contributing to the CF inflammatory pathology. We have shown that reduced amounts of PTEN protein represents a contributor to the etiology of CF lung pathology that is directly linked to CFTR itself, but not to Cl À channel function.
Lacking the ability to properly tether PTEN to the cell surface where it can participate in PI3K-mediated regulation of TLRMyD88-TIRAP signaling, CF immune and epithelial cells are limited to other mechanisms to control NF-kB signaling. CF cells with insufficient amounts of active PTEN were unable to maintain p110d-g PI3K activity or to generate phospho-Akt to control pro-inflammatory signaling. Although decreased activation of PI3K-dependent phospho-Akt and increased NF-kB inflammatory responses have been previously described in CF cells (Zhang et al., 2015; Zhang et al., 2013) , no direct association with CFTR itself was provided. Our studies extended these observations to indicate that specific CFTR mutations are directly linked to inflammatory regulation and that specific mutations that can be targeted with the available CFTR corrector-potentiator drugs should function to improve airway inflammation.
Our data demonstrated that PTEN complexed to CFTR promoted intracellular P. aeruginosa killing in human immune cells. Exactly how CFTR-PTEN regulated bacterial killing is under investigation. However, it has been shown that the CFTR scaffold drives bacterium-containing phagosome acidification (Di et al., 2006) , a phenomenon that can be explained by PTEN function as it promotes endosome-to-lysosome fusion (Naguib et al., 2015; Shinde and Maddika, 2016) and killing of two independent experiments (7 mice in total per group). Data is presented as average ± SEM. For (C), (D), (F), and (G) two-way ANOVA was used. For (E), Student's t-test was employed. *p < 0.05; **p < 0.005; ***p < 0.001; ****p < 0.0001. mycobacteria and mycoplasma (Huang et al., 2012) . Thus, a limitation in the scaffold function of CFTR over PTEN could explain the observed defect in the killing of intracellular pathogens by CF monocytes. Since the discovery of CFTR, six different mutation classes have been reported to be linked with CF disease (Elborn, 2016) . Our work provided evidence that CFTR pharmacological therapy aimed to treat type II and III variants effectively increased intracellular amounts of both the Cl À channel and the tumor suppressor PTEN in monocytes, supporting our hypothesis that these proteins interacted. CFTR has been suggested to act as a tumor suppressor (Than et al., 2016; Xie et al., 2013) , an observation that could be explained by its association with PTEN. Given the major role of PTEN as a tumor suppressor, it is tempting to speculate that impaired PTEN activity contributes to the increased prevalence of malignancies in the CF population, which are increasingly apparent as the CF population ages (Maisonneuve et al., 2013) . The immune deregulation seen in CF appears to correlate with the nature of the CFTR mutation. We predict that the continued development of more effective CFTR correctors-potentiators, even with limited ability to improve Cl À transport may, nonetheless, improve pulmonary function. Assessing relative PTEN abundance in CF PBMCs may be useful in predicting efficacy of CFTR directed therapy because it would provide a surrogate measurement for improved immunoregulatory capabilities. Lastly, the results presented in this work provided evidence that in addition to the decreased and more acidic airway liquid surface (ALS) in CF lungs that favor P. aeruginosa infection, intracellular deregulation of a tumor suppressor with immunomodulatory activities also contributes to the inflammatory pathology.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: In Vitro PAK Infection Experiments THP-1, C38 or IB3-1 cells were challenged with MOI = 10 of PAK or PBS during 1h in antibiotic-free medium, as previously described (20, 6), washed twice with PBS and gentamicin was added. For cytokine secretion studies, supernatants were harvested at different time-points and numbers of viable cells per well was counted. Cytokine production was standardized by the total amount of viable cell (fentrogram of protein per living cells). For intracellular flow cytometry staining, at different time-points cells were treated as described above in the protocol for intracellular detection of proteins by flow cytometry.
Western Blots
For CFTR rescued cells, either DF508 CF cells (treated with an empty vector) or rescued cells treated with a cftr-expressing lentivirus (WT CFTR) were grown in 75cm 2 cell culture flask and once reached 80%-90% confluency, cells were detached with Tryple-Express solution and counted. 2x10 6 cells were lysed with RIPA solution and samples were prepared for Western Blots. Samples were heated at 37C for 20min to avoid precipitation of CFTR. 40uL of samples were loaded into a 4%-10% Bis-Tris Plus gel (Invitrogen) and migrated. Gels were transferred to a nitrocellulose membrane by using iBlot Dry blotting system (Invitrogen). Membranes were blocked for 1h with 5% milk-TBST and stained for 1h with either anti-PTEN, anti-phospho PTEN, anti-phospho Akt, anti-phospho p85, anti-CFTR or anti-b Actin in the same blocking solution. Membranes were revealed in a Protein Simple FluorChem M camera. For WB of human samples, 4ml of blood collected by venipuncture from healthy or CF patients were passed to a vacutainer tube to recover PBMCs by differential centrifugation. Cells were recovered, washed twice with PBS and resuspended in 300uL of RIPA containing protease/phosphatase inhibitors. Samples were incubated for 30-45min on ice and then were centrifuged at 15000 g for 20min. Protein-containing supernatants were recovered and stored at À80C. To run western blots, samples were heated at 37C for 20min to avoid precipitation of CFTR. 50uL of samples were loaded into a 10% Bis-Tris Plus gel for PTEN/Actin and 4%-12% Bis-Trus Plus gel for CFTR/p110d and migrated in MES or MOPs buffer, respectively. Gels were transferred to a nitrocellulose membrane by using iBlot Dry blotting system (Invitrogen). Membranes were blocked for 1h with 5% milk-TBST and stained ON with either anti-PTEN, anti-CFTR, anti-p110d or anti-b Actin in the same blocking solution. Mbs were washed and stained with secondary antibodies. Membranes were revealed in a Protein Simple FluorChem M camera.
CFTR 2 Server www.cftr2.org was used to recover information for the infectious P. aeruginosa rate in CF patients. An array of characteristic type I, II, III, IV and V CFTR mutations observed in the population was chosen.
I-TASSER and CFTR-PTEN Interaction Modeling
For I-TASSER modeling, the last 100 amino acids corresponding to the human CFTR residue sequence were submitted to the I-TASSER server (http://zhanglab.ccmb.med.umich.edu/I-TASSER) to model its 3D structure. A PDB was generated and used to run ClusProV2 docking interaction models with PTEN. For CFTR-PTEN interaction modeling, ClusPro V2 online server (https:// cluspro.bu.edu/login.php) from the University of Boston was used to predict the possible interactions between the NBD2 domain of human crystallized CFTR and PTEN. Both CFTR and PTEN protein data bank files (PDBs) containing the 3D structures were acquired free from literature available in Pubmed (cited in the main text). Both PBDs were submitted to ClusPro V2 and 70,000 possible interactions were analyzed. Four major docking candidates were selected. These structures were saved as PDB files, analyzed with MacPyMOL and plotted.
PTEN/CFTR Detection in PBMCs 5mls of blood from either healthy controls or CF patients was obtained by venipuncture. Samples were centrifuged and the buffy-coat was recovered. Purification of the three lineages (granulocytes, monocytes and lymphocytes) was confirmed by Forward-Side (FSCA-SSC) Scatterplots by flow cytometry. The PBMC cellular fraction was washed twice in PBS in a 1.5ml Eppendorf and stained for intracellular proteins as described in the Intracellular detection of proteins by flow-cytometry procedure mentioned above.
Confocal Microscopy Studies THP-1, non-rescued or rescued DF508 CF cells were grown on a sterile 12mm coverslip in a 24well plate. Cells were infected or not with GFP-expressing PAK at MOI = 10 or pulsed with equal volume of PBS for 1h, in free-antibiotic containing medium. Cells were washed and treated with gentamicin-containing medium for an extra hour, washed twice with PBS and fixed with 2% PFA for 20min at 4C. Samples were washed twice with cold PBS and permeabilized with 0.05% Saponin-2% FBS-PBS (permeabilization buffer, PB) during 10min at RT. Next, volume was removed and coverlips were passed to a wet chamber where they were treated with 50uL of 1:500 diluted antibodies in PB against either PTEN or CFTR. Cells were incubated overnight at 4C, then washed four times with cold PBS. Cells were stained with 50uL of 1:500 diluted secondary antibodies in PB. Samples were incubated for 2.5h at 4C and then washed four times with PBS. Samples were mounted on slides with Prolong-DAPI solution, incubated at room temperature for 24h to allow Prolong polymerization and then stored at 4C. Slides were analyzed in a Nikon Ti Eclipse inverted microscope for scanning confocal microscopy. 0.2um Z stack were taken for each cell analyzed in a 1024x1024 resolution. Photo analyses was performed with FIJI software.
CFTR and PTEN Immunoprecipitation Assays 200ug of rGST-CFTR 1381-1480 (Creative BioMart) was attached to a GST purification column (Thermofisher) following manufacter instructions. 20ug of His-tagged rPTEN (Cayman chemicals) was added to the column and incubated under rotation overnight at 4C. In parallel, His-tagged rPTEN was incubated with 100ug of rGST (Abcam). Then, columns were eluted with elution buffer and a Western Blot for input and elutions was performed.
CFTR-PTEN Capture Assays by ELISA Flat-bottom ELISA plates were activated overnight at 4C with serial dilutions with either His-Tagged rPTEN or rGST-CFTR. Plates were washed twice with PBS. Wells were blocked with 10% FBS-PBS for 2h in the dark at room temperature. Plates were washed twice and 100uL of 16HBE lysate (RIPA extracted) added per well. Incubation was during 2h at RT. Wells were washed three times with PBS and either 50uL of 1:100 of anti-CFTR or 50uL of 1:400 anti-PTEN was added per well. Incubation lasted 1h and wells were washed three times with PBS and 100uL of 1:20000 IgG-HRP anti Rb IgG (for CFTR) or IgG-HRP anti Ms IgG (for PTEN) was applied. Wells were incubated for 1h at room temperature in the dark. Then samples were washed seven times with PBS and 100uL of TMB was added. Reaction was stopped with 50uL of 2N H 2 SO 4 and a 450nm readout was performed in a TECAN reader machine.
PTEN Transfection Experiments
Either WT/WT CFTR epithelial cells (16HBE) or DF508/DF508 epithelial CF cells (CFBE) were transfected either with a pten-gfp coding pcDNA3 plasmid (Addgene number 10759) or a gfp coding pcDNA3 plasmid (Addgene number 13031) by using lipofectamine 3000 technology. Cells were left under transfection during 48h, washed and intracellular staining by flow cytometry was performed against p110d. p110d levels were analyzed inside the gate of GFP + cells in FlowJo (either GFP + or PTEN-GFP + ).
Proximity Ligation Assays (PLA)
Human epithelial cells (16HBE) were grown up to 80% confluency, detached, counted and seeded (200,000 cells/well) in a 24-wells plate containing 12mm sterile coverslip. After attached at 37C (5h), cells were fixed for 30min at 4C with 2% PFA. Then, cells were washed and permeabilized with 0.05% Saponin-PBS-2% FBS for 10min at RT. Cells-containing wells were passed to a wet chamber and 50uL of a mix containing both mouse-anti CFTR and rabbit-anti PTEN diluted in 0.05% Saponin-PBS-2% FBS was added (1/100 dilution for each antibody). Control wells were treated only with 50uL of 0.05% Saponin-PBS-2% FBS. Cells were incubated at 4C ON. After ON incubation, wells were washed four times with 200uL of PBS each. PLA probes Minus and Plus were prepared as described by the manufacturer (Sigma) in a dilution 1/5 in 0.05% Saponin-PBS-2% FBS. Wells were treated with 50uL of the PLA probes during 1h at 37C. Cells were washed and treated with 50uL of 1/5 diluted Ligase for 40min. The reaction of amplification was performed by adding 50uL of 1/80 diluted Polymerase reaction kit to the cells at 37C during 1.5h. Cells were washed four times with PBS and mounted using Hoechst. Coverslips were sealed with nail polish and analyzed in a Confocal Microscopy.
Gentamicin Protection Assays
Either BMDMs, human monocytes (THP-1) or PBMCs were infected with PAK at MOI = 10 for 1h. Then, cells were washed and incubated with gentamicin-containing medium. When indicated, bpv(HOpic) was added to inhibit PTEN phosphatase function, as well as CFTR inh172 to block CFTR gating function and Cl À transport. At different time points cells were washed, detached and
counted. An aliquot of 10uL was plated on LB agar. After ON incubation, CFU recovered were counted and standardized against the total amount of living cells at the moment of the plating.
Ceramide Content Analysis
Human monocytes (THP-1 cells) were expanded, harvested and seeded in 24-well plates. Immediately after seeding with 1uM PMA for 24 hr to induce cell differentiation, cells were treated or not with 10 mM of CFTRinh 172 during 24h. Then, medium was replaced by fresh new one free of CFTRinh 172 and cells were incubated for other 24h at 37C. Next, cells were harvested and analyzed by Gas Chromatography Mass Spectrometry (GC-MS) for total content of ceramides using Columbia Health Sciences core facilities.
DATA AND SOFTWARE AVAILABILITY
GraphPad Prism V7 (www.graphpad.com) was used to plot data and build correlation curves between CFTR and PTEN levels. Photoshop CS6 (http://www.photoshop.com) was used to create figures. MacPyMOL (https://pymol.org/2) was used to obtain molecular images for protein-protein PDB readouts generated by the ClusPRO V2 supercomputer server (https://cluspro.bu.edu). FIJI-ImageJ (https://fiji.sc) was used for analyses of confocal microscopy images. Endnote (http://endnote.com) was used to the generation of citations in the manuscript. FlowJo VX (https://www.flowjo.com) was used to analyze flow cytometry data.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistics t-Student comparison was performed between two groups with one variable of difference. One-Way ANOVA was used to analyze three or more groups. Two-Ways ANOVA was used to compare a variable between multiple groups along time. Differences were considered as significant when p < 0.05.
